Viewing Study NCT01122251


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:38 PM
Study NCT ID: NCT01122251
Status: COMPLETED
Last Update Posted: 2011-02-18
First Post: 2010-05-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Sponsor: LG Life Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module